Vitamin D & its analogues in type 2 diabetic nephropathy: A systematic review

被引：31

作者：

Chokhandre M.K. ^{[1
]}

Mahmoud M.I. ^{[1
]}

Hakami T. ^{[1
]}

Jafer M. ^{[2
]}

Inamdar A.S. ^{[2
]}

机构：

[1] Department of Clinical Pharmacology, Faculty of Medicine, Jazan University, Jazan

[2] Department of Preventive Dental Sciences, College of Dentistry, Jazan University, Jazan

来源：

Journal of Diabetes & Metabolic Disorders | / 14卷 / 1期

关键词：

25 (OH) vitamin D; Kidney functions; Systematic review; Type 2 diabetic nephropathy; Vitamin D analogue;

D O I：

10.1186/s40200-015-0186-6

中图分类号：

学科分类号：

摘要：

Nephropathy is one of the major complications of diabetes often leading to chronic kidney disease (CKD). Inflammation and oxidative stress are associated with pathogenesis of diabetic nephropathy (DN) and found to be regulated by nuclear receptors such as vitamin D receptors (VDR). Vitamin D and its analogues have been effectively used in patients with CKD. The review attempts to summarize the available evidence on the role of vitamin D in DN. Electronic databases (MEDLINE, EMBASE, and Cochrane Library) were searched for studies assessing the role of vitamin D or its analogues on kidney function in type 2 diabetic patients. Studies evaluating kidney functions (urinary albumin/protein creatinine ratio, albuminuria and eGFR) were included and quality and risk of bias assessment performed. Additionally effect on 25 (OH) vitamin D, calcium and HbA1c were evaluated. The mean or its % change along with their standard deviation (SD) was used for reporting our results. RevMan (V5.2) was used for data analysis. Six studies included in this review evaluated the role of cholecalciferol, calcitriol and paricalcitol in patients with DN. Study designs differed (three randomized, one non-randomized and two uncontrolled trials) with varying degree of quality and risk of biases. Vitamin D analogues showed significant improvement in kidney function in two randomized studies. None of the studies reported significant incidences of hypercalcemia. Vitamin D analogues show significant improvement of kidney function in DN. Randomized controlled trials with longer duration, comparing the efficacy of vitamin D and its analogues are needed. © 2015 Chokhandre et al.

引用

共 45 条

[1]

Guariguata L., Whiting D.R., Hambleton I., Beagley J., Linnenkamp U., Shaw J.E., Global estimates of diabetes prevalence for 2013 and projections for 2035, Diabetes Res Clin Pract, 103, 2, pp. 137-149, (2014)

[2]

Wada J., Makino H., Inflammation and the pathogenesis of diabetic nephropathy, Clin Sci, 124, 3, pp. 139-152, (2013)

[3]

Singh R., Alavi N., Singh A.K., Leehey D.J., Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation, Diabetes, 48, 10, pp. 2066-2073, (1999)

[4]

Mezzano S., Aros C., Droguett A., Burgos M.E., Ardiles L., Flores C., Et al., NF- B activation and overexpression of regulated genes in human diabetic nephropathy, Nephrol Dial Transplant, 19, 10, pp. 2505-2512, (2004)

[5]

Hasegawa G., Nakano K., Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy, Kidney Int, 40, 6, pp. 1007-1012, (1991)

[6]

Lin M., Yiu W.H., Wu H.J., Chan L.Y.Y., Leung J.C.K., Au W.S., Et al., Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy, J Am Soc Nephrol, 23, 1, pp. 86-102, (2012)

[7]

Kato K., Osawa H., Ochi M., Kusunoki Y., Ebisui O., Ohno K., Et al., Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy, Clin Endocrinol (Oxf), 68, 3, pp. 442-449, (2008)

[8]

Choudhuryb M.L.X.W.D., Nuclear hormone receptors as therapeutic targets, Diabetes Kidney., 170, pp. 209-216, (2011)

[9]

Dilip K., Deb Y.C., 1,25-Dihydroxyvitamin D3 suppresses high glucose-induced angiotensinogen expression in kidney cells by blocking the NF-{kappa}B pathway, Am J Physiol Renal Physiol, 296, 5, pp. F1212-F1218, (2009)

[10]

Guan X., Yang H., Zhang W., Wang H., Liao L., Vitamin D receptor and its protective role in diabetic nephropathy, Chin Med J (Engl), 127, 2, (2014)

← 1 2 3 4 5 →